Molecular characterisation of MEK1/2- and MKK3/6-like mitogen-activated protein kinase kinases (MAPKK) from the fox

Verena Gelmedin1, Markus Spiliotis, Klaus Brehm

  • 1University of Würzburg, Institute of Hygiene and Microbiology, Würzburg, Germany.

Insights

Researchers identified two mitogen-activated protein kinase kinases (MAPKKs) in Echinococcus multilocularis, a parasite causing alveolar echinococcosis. These molecules, EmMKK1 and EmMKK2, are crucial for parasite development and stem cell function.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mitogen-activated protein kinase kinases (MAPKKs) are vital for cellular processes in response to stimuli.
  • No MAPKK orthologs have been characterized in parasitic flatworms previously.
  • Echinococcus multilocularis causes alveolar echinococcosis in humans.

Purpose of the Study:

  • Identify and characterize MAPKK orthologs in Echinococcus multilocularis.
  • Investigate the roles of these MAPKKs in parasite signaling pathways.
  • Explore potential therapeutic targets for alveolar echinococcosis.

Main Methods:

  • Degenerative PCR and RACE techniques for gene identification.
  • Yeast two-hybrid and co-immunoprecipitation assays for protein interactions.
  • Reverse transcriptase-PCR for gene expression analysis.
  • Small-molecule inhibitors to assess pathway function.

Main Results:

  • Two MAPKKs, EmMKK1 and EmMKK2, were identified and cloned from E. multilocularis.
  • EmMKK1 showed protoscolex-specific expression, while EmMKK2 was expressed in larval stages.
  • EmMKK2 interacts with EmRaf, a 14-3-3 protein, and EmMPK1, forming an Erk-like MAPK cascade.
  • Inhibiting Raf and MEK kinases affected parasite growth but not vesicle killing.

Conclusions:

  • EmRaf, EmMKK2, and EmMPK1 constitute the Erk-like MAPK cascade in E. multilocularis.
  • This signaling pathway is essential for parasite development and stem cell regulation.
  • The identified components offer potential targets for anti-parasitic therapies.